Natco Pharma Ltd Xpreza Azacitidine Injection

Name: Natco Pharma Ltd Xpreza Azacitidine Injection
Brand: BALAJI CHEMICAL STORES
Price: 2000.0 INR
Availability: InStock

Price 2000.0 INR/ Box

Get a Price/Quote

MOQ : 10 Boxes

Natco Pharma Ltd Xpreza Azacitidine Injection Specification

Salt Composition
Azacitidine

Pacakaging (Quantity Per Box)
1 Vial per box

Origin of Medicine
India

Packaging Type
Vial and carton box

Indication
Used in the treatment of Myelodysplastic syndromes

Life Span
See pack for expiry

Dosage Form
Lyophilized powder for injection

Brand Name
Xpreza

Drug Type
Prescription only (Rx)

Ingredients
Azacitidine

Physical Form
Injection

Function

Recommended For
For patients with Myelodysplastic Syndromes

Dosage
As directed by physician

Dosage Guidelines
For subcutaneous or intravenous use only

Suitable For
Adults

Quantity
100 mg/vial

Storage Instructions
Store below 25C

Therapeutic Class
Antineoplastic agents

Language on Pack
English and Hindi

Route of Administration
Subcutaneous or Intravenous

Strength
100 mg

About Natco Pharma Ltd Xpreza Azacitidine Injection

Azacitidine for injection is a nucleoside analog used to treat myelodysplastic syndromes and acute myeloid leukemia. It restores normal blood cell production by inhibiting abnormal DNA methylation. Administered subcutaneously or intravenously, it improves survival, delays disease progression, and reduces transfusion dependence.

Effective Treatment for Myelodysplastic Syndromes

Xpreza Azacitidine Injection delivers proven antineoplastic activity for patients diagnosed with Myelodysplastic Syndromes. As part of a chemotherapy regimen, it helps slow disease progression and improve blood cell production when administered by a healthcare professional.

Easy-to-Use Lyophilized Powder Formulation

Supplied as a lyophilized powder, Xpreza is reconstituted before administration, making it versatile for both subcutaneous and intravenous routes. Its packaging ensures consistent dosing and convenient handling in clinical settings.

Strict Storage and Handling Safety

Xpreza must be stored below 25C and kept in its original packaging until use to maintain potency and safety. Always check the expiry date before preparing the injection.

FAQ's of Natco Pharma Ltd Xpreza Azacitidine Injection:

Q: How is Xpreza Azacitidine Injection administered?

A: Xpreza Azacitidine Injection is administered either subcutaneously (under the skin) or intravenously (into a vein) by a healthcare professional, following your doctor's prescription and dosage instructions.

Q: What is the primary use of Xpreza Azacitidine Injection?

A: This medication is primarily used for treating adults with Myelodysplastic Syndromes (MDS), a group of diseases that affect bone marrow function and blood cell production.

Q: When should I receive Xpreza Azacitidine Injection?

A: Your physician will determine the treatment schedule based on your specific medical condition and response to therapy. It is important to follow the schedule provided by your healthcare provider.

Q: Where can I find information on the expiry date and storage of this injection?

A: The expiry date is printed on the vial or carton box. Store the product below 25C and keep it in its original packaging until use to ensure product stability.

Q: What is the process for preparing Xpreza Azacitidine Injection for use?

A: A healthcare professional will reconstitute the lyophilized powder with sterile water according to the manufacturer's guidelines before administering it to the patient.

Q: What are the benefits of using Xpreza in patients with Myelodysplastic Syndromes?

A: Xpreza helps manage symptoms by supporting normal blood cell production and slowing the progression of Myelodysplastic Syndromes, thereby improving quality of life and treatment outcomes.

Tell us about your requirement